OPS
CYTK icon

Orion Portfolio Solutions’s Cytokinetics CYTK Stock Holding History

Orion Portfolio Solutions’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,168
Closed -$222K – 1727
2024
Q1 		$222K Buy
+3,168
New +$245K ﹤0.01% 1577
2020
Q3 		– Sell
-67
Closed -$2K – 784
2020
Q2 		$2K Buy
+67
New +$1.26K ﹤0.01% 1748

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Orion Portfolio Solutions's CYTK Position: Q2 2024 in Review

Orion Portfolio Solutions sold out of Cytokinetics (CYTK) in Q2 2024, closing a stake of 3,168 shares — an estimated $222K sold.

Orion Portfolio Solutions first reported a position in CYTK in Q2 2020 and held it in 2 quarters. The position peaked at $222K in Q1 2024. 343 funds tracked by Wall St. Rank hold CYTK as of Q2 2024.

  • Orion Portfolio Solutions reported no remaining Cytokinetics position as of Q2 2024 after selling out during the quarter.
  • Orion Portfolio Solutions sold 3,168 Cytokinetics shares in Q2 2024, an estimated $222K.
  • Orion Portfolio Solutions first reported a position in Cytokinetics in Q2 2020 and held it in 2 quarters.
  • Orion Portfolio Solutions's Cytokinetics position peaked at $222K in Q1 2024.
  • 343 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2024.

Based on Orion Portfolio Solutions's 13F filing for Q2 2024, filed 13 Aug 2024.